Can Ficicioglu
8PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 14, 2026
Improvement of Bone Mineral Density in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: Results from Clinical Studies.Ari Zimran, Jaco Botha, Richard Eastell
|Sep 22, 2025
Novel Phenotypic Insights into the IDS c.817C>T Variant in Mucopolysaccharidosis Type II from Newborn Screening Cohorts.Éliane Beauregard-Lacroix, Caitlin Menello, Madeline Steffensen
|Apr 14, 2025
Genotype/Phenotype Relationship: Lessons From 137 Patients With PMM2-CDG.Sander Pajusalu, Mari-Anne Vals, Mercedes Serrano
|Mar 26, 2025
Five-Year Outcomes of Patients with Pompe Disease Identified by the Pennsylvania Newborn Screen.Hayley A Ron, Owen Kane, Rose Guo
|Oct 24, 2022
Addition of MPS-II to the Recommended Uniform Screening Panel in the United States.David S Millington, Can Ficicioglu
|Dec 01, 2020
Diagnostic journey and impact of enzyme replacement therapy for mucopolysaccharidosis IVA: a sibling control study.Can Ficicioglu, Dena R Matalon, Nicole Luongo
Pageof 2
Frequent Collaborators
2 joint publications
Caitlin Menello
1 joint publications
Roberto Giugliani
1 joint publications
Nicole Engelhardt
1 joint publications
Sander Pajusalu
1 joint publications
Mercedes Serrano
1 joint publications
Peter Witters
1 joint publications
Anna Cechova
1 joint publications
Tomáš Honzik
1 joint publications
Andrew C Edmondson
1 joint publications
Rita Barone
